Replies to post #147088 on Biotech Values

[biomaven0]

Sorry - I must not have been clear in my posting. I was saying there is the risk in this pain indication of the same issue as happened in RA (loss of efficacy over time) showing up here too. Hence I was agreeing they need to run a longer trial.

So we are on the same page here.

Peter